CDEK
← All drugs Report issue

autologous regulatory t cells

Cell therapyexperimental

Clinical trial activity

42 trials · 44 clinical orgs · 0 marketing orgs

Phase 1
33
Phase 2
21
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2007 (NCT00376519)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

  • Unspecified targetTissue restoration

    Tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • autologous regulatory t cells
  • expanded tregs
  • polyclonal regulatory t cells
  • regulatory t cells
  • regulatory t-cells
  • treg cell
  • t-reg cells
  • treg cells
  • t regulatory cell
  • t regulatory cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06991361Phase 1Sep 1, 2025Harvard University
NCT06688331Phase 2Dec 31, 2024Government of Poland, PolTREG S.A.
NCT06427421N/AJun 30, 2024Assistance Publique - Hôpitaux de Paris, Institut National de la Santé Et de la Recherche Médicale, France
NCT05973734Phase 1Oct 1, 2023Stanford University, University of California, San Francisco
NCT06052436Phase 1/Phase 2 (Phase 2)Jun 27, 2023Hospital General Universitario Gregorio Marañon, Universidad Carlos III Madrid
NCT05566977Phase 1Dec 31, 2022Ain Shams University
NCT05214014Phase 1/Phase 2 (Phase 2)Sep 1, 2022Belarusian State Medical University, National Academy of Sciences of Belarus
NCT05386264Phase 1Jul 14, 2022University of London
NCT05095649Phase 2Dec 15, 2021Fundación Pública Andaluza, University of Seville
NCT05088356Phase 1Sep 7, 2021Orca Biosystems, Inc., Stanford University
NCT04737161Phase 1Mar 31, 2021Stanford University
NCT04691232Phase 1Aug 26, 2020University of Erlangen-Nuremberg
NCT04055623Phase 2Sep 1, 2019Harvard University, Northeast ALS Consortium, The University of Texas, Dallas, University of Texas at Houston
NCT03865017Phase 1/Phase 2 (Phase 2)Jun 21, 2019BHT Lifescience Austrailia Pty Ltd., GMP BIO Co., LTD.
NCT03867617Phase 1/Phase 2 (Phase 2)Apr 30, 2019Medical University of Vienna, University of Regensburg
NCT03654040Phase 1/Phase 2 (Phase 2)Oct 1, 2018Immune Tolerance Network, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco
NCT03683498Phase 1Sep 17, 2018Fundación Pública Andaluza, University of Seville
NCT04820270N/AAug 20, 2018Karolinska Institute, The Nordic Network For Clinical Islet Transplantation
NCT03460795Phase 1/Phase 2 (Phase 2)Apr 1, 2018Nanjing Medical University
NCT03239470Phase 1Sep 22, 2017National Institute of Allergy and Infectious Diseases (NIAID), University of San Francisco
Showing 20 of 42 trials
Page 1 / 3

Organizations

Research & Development (44)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Stanford UniversityAcademic/Hospital6622009
University of MinnesotaAcademic/Hospital5422007
Harvard UniversityAcademic/Hospital4322013
University of California, San FranciscoAcademic/Hospital4122014
Nanjing Medical UniversityAcademic/Hospital3322014
National Cancer Institute (NCI)Government3022013
National Institute of Allergy and Infectious Diseases (NIAID)Government3322016
National Institutes of Health (NIH)Government3022011
University of LondonAcademic/Hospital3322014
Assistance Publique - Hôpitaux de ParisAcademic/Hospital2222013
Fundación Pública AndaluzaAcademic/Hospital2222018
University of RegensburgAcademic/Hospital2022014
University of SevilleAcademic/Hospital2022018
University of Texas at HoustonAcademic/Hospital2112015
Ain Shams UniversityAcademic/Hospital1112022
Belarusian State Medical UniversityAcademic/Hospital1012022
BHT Lifescience Austrailia Pty Ltd.For profit1012019
Chu De LiègeAcademic/Hospital1012013
Clinical Trials in Organ TransplantationGovernment1012016
Doris Duke Charitable FoundationAcademic/Hospital1012009
44 organizations
Page 1 / 3